SYP and neoplasm: Given the unusual molecular findings and methylome features not entirely consistent with typical DLGNT (yet displaying MAPK pathway alteration and 1p loss, with Olig2 positivity and rare cells with synaptophysin immunoreactivity), the tumor was ultimately diagnosed as a glioneuronal neoplasm with worrisome molecular features, NEC.